Cell Genesys shares plummet; lose 75 percent of value

wrote an interesting post today on
Here’s a quick excerpt
South San Francisco-based Cell Genesys Inc., the developer of an immune-system booster tested against prostate cancer, lost three-fourths of its value in Nasdaq trading after reporting that more people died on …

Read the rest of this great post here

This entry was posted on Wednesday, August 27th, 2008 at 1:17 pm and is filed under Prostate Cancer Info. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.